Jean-Jacques Morgenthaler

Title: Innovations of Jean-Jacques Morgenthaler

Introduction

Jean-Jacques Morgenthaler is a notable inventor based in Boll, Switzerland. He has made significant contributions to the field of protein solutions, particularly in the removal of harmful agents and viruses. With a total of 3 patents, Morgenthaler's work has implications for medical and biotechnological applications.

Latest Patents

Morgenthaler's latest patents include a method for the removal of causative agent(s) of transmissible spongiform encephalopathies from protein solutions. This innovative method involves suspending at least one adsorbent, such as kieselguhr or diatomaceous earth, in a protein solution for a minimum of 10 minutes. The adsorbent is then agitated and separated from the protein solution, effectively removing non-conventional transmissible agents. Another significant patent focuses on the removal of viruses from protein solutions. In this method, solid phase particles are suspended in the protein solution, allowing for the separation of viruses that have adsorbed to the solid phase. This process also requires at least 10 minutes of contact time before separation.

Career Highlights

Throughout his career, Morgenthaler has worked with reputable companies such as ZLB Bioplasma AG and Rotkreuzstiftung Zentrallaboratorium Blutspendedienst SKR. His experience in these organizations has contributed to his expertise in the field of biopharmaceuticals and protein purification.

Collaborations

Morgenthaler has collaborated with professionals like Adames Omar and Jacques-Andre Maring, further enhancing his research and development efforts in the industry.

Conclusion

Jean-Jacques Morgenthaler is a distinguished inventor whose innovative methods for purifying protein solutions have the potential to advance medical and biotechnological fields. His contributions are invaluable, and his patents reflect a commitment to improving safety in protein-based products.